World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 7467370

Number of visits today: 3441

Number of downloads: 4924546

PUBLISHING PARTNER

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (852)

Contents Volume 2 Issue 3 March 27, 2010

Editorial

Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B

Konstantinos Tziomalos

World J Hepatol 2(3):91-93. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.91

Abstract (1248) | Core Tip (859) | Full Article (HTML) (2519) | Full Article (PDF)-515K (339) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (6) | Total Visits (5110) | Similar Articles (2045) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines for Basic Science

Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma

Yu-Jing Zhang

World J Hepatol 2(3):94-102. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.94

Abstract (1254) | Core Tip (944) | Full Article (HTML) (4017) | Full Article (PDF)-707K (399) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (27) | Total Visits (6763) | Similar Articles (1864) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines for Clinical Practice

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

Camillo Porta, Chiara Paglino

World J Hepatol 2(3):103-113. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103

Abstract (1217) | Core Tip (902) | Full Article (HTML) (3057) | Figures (1-2) (495) | Tables (1-3) (485) | Full Article (PDF)-857K (364) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (6715) | Similar Articles (1864) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Review

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma

Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli

World J Hepatol 2(3):114-126. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.114

Abstract (1325) | Core Tip (889) | Full Article (HTML) (8108) | Figures (1-3) (486) | Tables (1-2) (595) | Full Article (PDF)-880K (647) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (39) | Total Visits (12246) | Similar Articles (1937) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Brief Article

Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

Maria Pleguezuelo, Laura M Lopez-Sanchez, Antonio Rodriguez-Ariza, Jose L Montero, Javier Briceno, Ruben Ciria, Jordi Muntane, Manuel de la Mata

World J Hepatol 2(3):127-135. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127

Abstract (1326) | Core Tip (880) | Full Article (HTML) (4517) | Figures (1-4) (446) | Tables (1-2) (506) | Full Article (PDF)-862K (605) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (12) | Total Visits (8453) | Similar Articles (0) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Case Report

Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination

Sudeep Tanwar, Mark Thursz

World J Hepatol 2(3):136-138. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.136

Abstract (1512) | Core Tip (916) | Full Article (HTML) (2728) | Full Article (PDF)-510K (305) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (5615) | Similar Articles (236) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345